Evidence map›Paper›PMID 40858567›Full record

ArticleNature communications2025

Multiplex bead assays enable integrated serological surveillance and reveal cross-pathogen vulnerabilities in Zambezia Province, Mozambique.

Andrea C Carcelen, Celso Monjane, Sophie Bérubé, Saki Takahashi, Thebora Sultane, Imelda Chelene, Gretchen Cooley, E Brook Goodhew, Catriona Patterson, Kevin Tetteh and 9 more

Erratum issuedAbstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Differences in novelFrontiers in parasitology · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Andrea C CarcelenDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. acarcel1@jh.edu.ORCID http://orcid.org/0000-0001-6271-6387
Celso MonjaneInstituto Nacional de Saúde, Maputo, Mozambique.
Sophie BérubéDepartment of Biostatistics, The University of Florida, Gainesville, FL, USA.
Saki TakahashiDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-5413-5507
Thebora SultaneInstituto Nacional de Saúde, Maputo, Mozambique.
Imelda CheleneInstituto Nacional de Saúde, Maputo, Mozambique.
Gretchen CooleyDivision of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA.
E Brook GoodhewDivision of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Catriona PattersonDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK.ORCID http://orcid.org/0000-0002-4500-7199
Kevin TettehDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK.
Manuel MutambeInstituto Nacional de Saúde, Maputo, Mozambique.
Melissa M HigdonDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-1932-9442
George MwinnyaaDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Gilberto NhapureInstituto Nacional de Estatística, Maputo, Mozambique.
Pedro DuceInstituto Nacional de Estatística, Maputo, Mozambique.
Diana L MartinDivision of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Christopher DrakeleyDepartment of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK.ORCID http://orcid.org/0000-0003-4863-075X
William J MossDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Ivalda MacicameInstituto Nacional de Saúde, Maputo, Mozambique.

Funding

Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) 125027Wellcome Trust 060109
6 · The paper itself

Abstract

Multiplex serological assays simultaneously measure antibodies to multiple antigens, furnishing insights into exposure and susceptibility to several pathogens and cross-pathogen vulnerabilities. Our serosurvey tests dried blood spots from 1292 individuals for IgG antibodies to 35 antigens from 18 pathogens using a multiplex bead assay for vaccine preventable diseases, malaria, SARS-CoV-2, neglected tropical diseases, and enteric pathogens in Mozambique. We produce pathogen-specific seroprevalence estimates and age-seroprevalence curves and identify spatial differences in seroprevalence. Rural clusters have higher odds of seropositivity to most NTDs neglected tropical diseases, Plasmodium falciparum malaria, and enteric pathogens, but lower odds of seropositivity to SARS-CoV-2 and vaccine preventable diseases compared to urban clusters. This co-occurrence identifies clusters with high vulnerability to multiple pathogens. We identify a candidate group of antigens that are correlated with high overall vulnerability. Our results demonstrate a role for multiplex serology in integrated disease surveillance to guide control strategies for individual and co-endemic pathogens.

Indexed as

COVID-19Serologic TestsAdolescentAdultAgedChildChild, PreschoolFemaleHumansImmunoglobulin GInfantMalariaMalaria, FalciparumMaleMiddle AgedMozambiqueImmunoglobulin G

Identifiers

PMID40858567
PMCPMC12381283

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.